Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement

L Van Doeselaer, S Nicolay, W De Ridder - Acta Neurologica Belgica, 2024 - Springer
A 79-year-old male patient presented with subacute limbgirdle weakness five weeks after
the first infusion of immune checkpoint inhibitor (ICI) pembrolizumab, an adjuvant therapy …
相关文章

[引用][C] Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement.

L Van Doeselaer, S Nicolay… - Acta Neurologica Belgica, 2024 - europepmc.org
Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

[引用][C] Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement

L Van Doeselaer, S Nicolay… - Acta neurologica … - pubmed.ncbi.nlm.nih.gov
Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement
Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement …

[引用][C] Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement

L Van Doeselaer, S Nicolay… - Acta neurologica …, 2024 - repository.uantwerpen.be
Pembrolizumab-associated myositis with striking extraocular muscle contrast enhancement
- Institutional Repository University of Antwerp Publication Title Pembrolizumab-associated …